Showing results (1-10 of 166) with videos related to
Sort By:
Pageof 17
MMW Fortschritte Der Medizin|June 23, 2005
[Multiple sclerosis: between wish and reality]T Kümpfel, R HohlfeldDer Internist|February 28, 2015
[Immunotherapies for multiple sclerosis : review and update]J Havla, T Kümpfel, R HohlfeldDer Nervenarzt|September 24, 2002
[Antegren (natalizumab). A promising new approach to therapy of multiple sclerosis]T Kümpfel, N Heydari, R HohlfeldDer Nervenarzt|February 10, 2006
[Pregnancy and immunomodulatory therapy in multiple sclerosis patients]L A Hoffmann, T Kümpfel, I Heer, et al.Neurology|October 22, 2008
Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosisM Krumbholz, I Meinl, T Kümpfel, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 15, 2010
Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosisT Kümpfel, L A Gerdes, M Flaig, et al.Journal of Neuroimmunology|March 7, 2002
Treatment with glatiramer acetate induces specific IgG4 antibodies in multiple sclerosis patientsC Farina, V Vargas, N Heydari, et al.Neurology|November 26, 2008
Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 casesT Kümpfel, L-A Hoffmann, H Pellkofer, et al.Journal of Neurology|November 16, 2016
Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degenerationJoachim Havla, T Kümpfel, R Schinner, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2010
Concurrent TNFRSF1A R92Q and pyrin E230K mutations in a child with multiple sclerosisA Blaschek, P Lohse, K Huss, et al.Pageof 17